OUR EXPERTISE AND SERVICES AVAILABLE IN

Dermatology

Overview

Find syndicated market insights and custom brand analyses through our services offered in the dermatology market. Spherix’s independent research is conducted by market experts in collaboration with our proprietary network of dermatologists, patients, and leading KOLs.

Advisors

Dr. Alan Menter

Dermatology

Dr. Alan Menter

Dermatology

Dr. Alan Menter was born in England and is a graduate of the Medical School of the University of Witwatersrand, South Africa. He completed his dermatology residency at Pretoria General Hospital at the University of Pretoria, also in South Africa, and two fellowships in London at Guy's Hospital and St. John's Hospital for Diseases of the Skin. A fellowship with the University of Texas Southwestern Medical Center in Dallas brought Menter to the United States in 1975. Since then, he has held several positions within the UT and Baylor University Dallas systems. In 1992, he was appointed chairman of the Division of Dermatology at Baylor University Medical Center and still holds that position. In 2007, he was appointed director of the Baylor Research Center and in 2010, Program Director of the newly formed Dermatology Residency Program at Baylor University Medical Center.

Dr. Joseph Merola

Dermatology Rheumatology

Dr. Joseph Merola

Dermatology Rheumatology

Joseph F. Merola, MD, MMSc, is Associate Professor in the Department of Dermatology and Department of Medicine, Division of Rheumatology at Harvard Medical School in Boston, Massachusetts. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He serves as the Vice Chair for Clinical Trials, the Director of the Clinical Unit for Research Innovation and Trials (CUReIT), Director of the Center for Skin and Related Musculoskeletal Diseases and the Associate Program Director for the Harvard Combined Internal Medicine-Dermatology Residency Training Program at Brigham and Women’s Hospital in Boston. Dr. Merola earned his medical degree at New York University School of Medicine in New York, New York, followed by his Master of Medical Sciences degree at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania in Philadelphia, followed by a residency in Dermatology at New York University Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at Brigham and Women’s Hospital.

Dr. Mital Patel-Cohen

Dermatology

Dr. Mital Patel-Cohen

Dermatology

Dr. Patel-Cohen is a dermatologist specializing in autoinflammatory disease of the skin, with a focus on hidradenitis suppurativa. She completed a unique fellowship in Dermatology-Rheumatology at Brigham and Women's Medical Center. She is currently the Director of Complex Medical Dermatology at Summit Medical Group. Prior to joining Summit Medical Group, Dr. Patel-Cohen was an attending physician at Brigham and Women's Hospital and an assistant professor at Harvard Medical School. She was the founder and director of Brigham and Women's Hidradenitis Suppurativa and Neutrophilic Dermatoses Clinic and their Dermatology-Gastroenterology multidisciplinary clinic.

Dr. Andrew Blauvelt

Dermatology

Dr. Andrew Blauvelt

Dermatology

Dr. Blauvelt is President of Oregon Medical Research Center, a small business dedicated to performing high quality clinical research studies in dermatology. He received his undergraduate degree in electrical engineering at Purdue University, his medical degree at Michigan State University, and a healthcare MBA at Oregon Health & Science University (OHSU). Dr. Blauvelt trained in dermatology at the University of Miami and in cellular immunology under the direction of Dr. Steve Katz at the National Institutes of Health (NIH). Earlier in his career, he held senior staff positions at the NIH (Senior Investigator), OHSU (Professor), and the Portland VA Medical Center (Chief). Dr. Blauvelt's research and clinical expertise has been in Langerhans cell biology, T cell immunology, virology, psoriasis, and atopic dermatitis. He has published over 300 papers and spoken across the country and world on these topics. Within psoriasis research, his laboratory published key papers on the role of IL-23/Th17 biology in psoriasis; in recent years, he has been the international lead investigator on a number of important clinical trials, including PSTELLAR, FEATURE, IXORA-R, VOYAGE 1, IMMhance, CHRONOS, ECZTEND, JADE REGIMEN, and HEADS UP. Dr. Blauvelt is also an elected member of the American Society for Clinical Investigation, the International Psoriasis Council, the International Eczema Council, and the Scientific Advisory Committee of the National Psoriasis Foundation. In 2021, he made the list of Highly Cited Researchers, representing the top 1% of cited scientists in the world.

Related Content

LEARN MORE ABOUT DERMATOLOGY

Get more information on Dermatology Coverage